LifeSciVC

AUGUST 5, 2024

But that initial quote isn’t from 2024, it is from an interview in 2021 with Mark Levin, CEO at Millennium (MIT Technology Review). Hence, it is the powerful combination of genomics research with mechanistic biology employed today that drives strategy for development of the next generation of important medicines.

Molecular Biology 88

Molecular Biology Production Small Molecule Drug Development 88

Drug Discovery World

DECEMBER 26, 2023

Atropos Health and SEQSTER Real-world data company Atropos Health and SEQSTER, a provider of patient-centric healthcare data technology, have partnered to accelerate patient registries in clinical research. The collaboration will advance the speed-to-insight for many underrepresented populations served by registry-based research.

Small Molecule 130

Small Molecule Drugs Molecular Biology Bioinformatics 130

Drug Discovery World

JULY 23, 2024

For example, in 2021, of the 48 new therapeutic molecular therapies approved by the US Food and Drug Administration’s Center for Drug Evaluation and Research, 17 were approved as personalised medicines 2. From DDW Volume 25 – Issue 3, Summer 2024 Read the digital issue References: Maurano MT, Humbert R, Rynes E, et al.

DNA 130

DNA Disease Regulations Molecular Biology 130

Alta Sciences

AUGUST 21, 2024

Internships at Altasciences: Q&A With Our Summer Interns nbartlett Thu, 08/22/2024 - 04:44 Internships at Altasciences are more than just a stepping stone—they’re a gateway to real-world-experience and professional growth, giving the next generation opportunities to help shape progress in the drug development industry.

International 40

International Laboratories Science Molecular Biology 40

Drug Target Review

FEBRUARY 26, 2024

Her research focus is on epigenetic regulation of melanoma and other cancers as well as wound healing, ageing biology and the development of novel epigenetic therapies targeting cancers and skin diseases and she is the owner of 15 issued and pending patents relevant to her research. Dr Alani received her M.D.

Therapies 59

Therapies Molecular Biology Regulations Medical Schools 59

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). from 2024 to reach US$129.8 ’s services include supporting life sciences research, analytical solutions, and diagnostics or developing and manufacturing therapeutic interventions. billion by 2029.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Alta Sciences

MARCH 1, 2024

Q&A With Dr. Norbert Makori and Pierre Jolicoeur: The Benefits of Combining Preclinical and Bioanalytical for Your Gene Therapy Studies pmjackson Fri, 03/01/2024 - 22:20 Recent advances in gene therapy have allowed for diseases to be approached differently. q: How can Altasciences support sponsors’ Gene Therapy Programs?

Therapies 52

Therapies Laboratories Molecular Biology RNA 52

Broad Institute

APRIL 25, 2024

By Allessandra DiCorato April 25, 2024 As night fell on July 20th, 2014, genomicist Christian Happi was at home with his family in Lagos, Nigeria when he received a phone call he would never forget. Partnering with researchers on the ground to reach communities where they are is absolutely critical to making that a reality.” “We

Virus 132

Virus Hospitals Disease Government 132

Broad Institute

MAY 14, 2024

William Studier for development of widely used protein- and RNA-production platform By Corie Lok May 14, 2024 Breadcrumb Home Merkin Prize in Biomedical Technology awarded to F. By Broad Communications May 14, 2024 F. Studier will be honored in a prize ceremony held on September 17, 2024. Photo courtesy of BNL.

RNA 84

RNA Production Molecular Biology Laboratories 84

Drug Discovery World

APRIL 30, 2024

Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has begun to expand into areas of vaccinology, infectious diseases and other indications. As such, teams are now researching a variety of medical applications for mRNA-based drugs.

Therapies 130

Therapies RNA Vaccine Small Molecule 130

Broad Institute

JANUARY 30, 2024

More bottles on the medicine shelf would help, but Bhattacharyya, who’s now also a research scientist, realized that science might lead to better tools for diagnosing and treating such challenging cases. TWO WHITE COATS Roby Bhattacharyya's mother, Maryka, visiting his graduate research lab at UCSF.

Hospitals 137

Hospitals Medical Schools Virus Science 137

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Kielczewska will present: ‘Discovery of antibody-based therapeutics to challenging targets: Platform considerations’.

Engineering 130

Engineering Therapies Protein Production Science 130

Drug Target Review

FEBRUARY 28, 2024

Preclinical research on γδ T cells has made great strides since the cells were first identified in the 1980s, with γδ T-cell therapies from several companies, including IN8bio, now in or nearing clinical trials for various cancers. from 2003 to 2006, covering the biotechnology and life-science tools sectors.

Therapies 105

Therapies Engineering Molecular Biology Immune Response 105

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Miguel Gancedo Rodrigo Miguel Gancedo Rodrigo Research Investigator, Isomorphic Labs My name is Miguel, and I’m from Murcia, Spain.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Target Review

NOVEMBER 8, 2023

Vittoria was built on research conducted by Vittoria’s Scientific founder, Dr Marco Ruella, a physician-scientist and Assistant Professor of Medicine at the Center for Cellular Immunotherapies at Penn’s Perelman School of Medicine. About the author Dr Nicholas A.

Therapies 116

Therapies Engineering Molecular Biology Treatment 116

Drug Target Review

JULY 1, 2024

Scientific Reports 14, 11103 (2024). He was bestowed the 2024 NIH HEAL Director’s Trailblazer Award for this work. Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH.

Treatment 59

Treatment Clinical Trials Molecular Biology Therapies 59

Codon

JUNE 25, 2024

Due to the nearly ubiquitous use of cloning in life science research, this lost time adds up. Researchers use DNA cloning to make numerous copies of a gene, which can then be inserted into living cells to study how that gene functions or otherwise coax the cell to make proteins. However, E.

DNA 70

DNA RNA Laboratories Engineering 70

Codon

FEBRUARY 13, 2024

Goodsell, RCSB Protein Data Bank and Scripps Research. 1 Yet even after more than two decades of research, media hype, and dozens of clinical trials and biotech start-ups that have come and gone, phage therapy has not scaled. Still, researchers are trying. Read it on our website here. Illustration by David S.

Therapies 118

Therapies Virus DNA Clinical Trials 118

Codon

JUNE 18, 2024

Even after a half-century of molecular biology research, scientists didn’t know until recently how gas vesicles physically trap gas while occluding water. By 2016, Shapiro had set up a research laboratory at the California Institute of Technology in Pasadena and began to devote his attention entirely to gas vesicles.

Engineering 66

Engineering Laboratories International Clinical Trials 66

Agency IQ

JANUARY 19, 2024

BY RACHEL COE, MSC | JAN 17, 2024 12:16 AM CST Quick background on cell line development Despite technological advancements in synthetic biology, all biological products today make use of harvested cellular material (or “substrate”) in one way or another. the recombinant protein). The Specific Precautions section (6.2.7)

Virus 40

Virus Science Production FDA 40

Drug Target Review

FEBRUARY 15, 2024

To survive this era, governments, multi-lateral organisations, foundations, and industry will need to work collectively on researching and developing new drugs that can prevent or treat a broad range of epidemic-prone pathogens, some of which have not yet been identified. All of these factors are being further accelerated by climate change.

Drug Development 122

Drug Development Virus Vaccine Government 122